Epicardial fat thickness in patients with prediabetes and correlation with other cardiovascular risk markers

Internal Medicine

Volumn 54, Issue 9, 2015, Pages 1009-1014

  Arpaci, Dilek ^a   Ugurlu, Burcak Polat ^b   Aslan, Abdullah Nabi ^c   Ersoy, Reyhan ^b   Akcay, Murat ^b   Cakir, Bekir ^b  

^a SAKARYA UNIVERSITY   (Turkey)

^b YILDIRIM BEYAZIT UNIVERSITY   (Turkey)

^c ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Cardiovascular; Epicardial fat; Glucose; Prediabetic

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGE; AGED; ARTICLE; BLOOD PRESSURE; BODY MASS; BODY WEIGHT; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CONTROLLED STUDY; EPICARDIAL FAT THICKNESS; FEMALE; GENDER; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; SMOKING; WAIST CIRCUMFERENCE; BLOOD; CARDIOVASCULAR DISEASES; ECHOCARDIOGRAPHY; GLUCOSE INTOLERANCE; METABOLISM; MIDDLE AGED; PATHOLOGY; PERICARDIUM; RISK FACTOR;

ADULT; AGED; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; ECHOCARDIOGRAPHY; FEMALE; GLUCOSE INTOLERANCE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; PERICARDIUM; PREDIABETIC STATE; RISK FACTORS; TRIGLYCERIDES; WAIST CIRCUMFERENCE;

EID: 84928974687     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.54.3714     Document Type: Article

References (46)

1. Yach D, Stuckler D, Brownell KD. Epidemiologic and economic consequences of the global epidemics of obesity and diabetes. Nat Med 12: 62-66, 2006.
2. Lorenzo C, Williams K, Hunt KJ, Haffner SM. The National Cholesterol Education Program-Adult Treatment Panel III, InternationalDiabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes Care 30: 8-13, 2007.
3. World Health Organization. Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia. Report of a WHO/IDF Consultation. World Health Org, Geneva, 2006.
4. Temelkova-Kurktschiev TS, Koehler C, Henkel E, Leonhardt W, Fuecker K, Hanefeld M. Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level. Diabetes Care 23: 1830-1834, 2000.
5. Petersen JL, McGuire DK. Impaired glucose tolerance and impaired fasting glucose-a review of diagnosis, clinical implications and management. Diab Vasc Dis Res 2: 9-15, 2005.
6. Aykan AÇ, Gül I, Gökdeniz T, et al. Ankle brachial index intensifies the diagnostic accuracy of epicardial fat thickness for the prediction of coronary artery disease complexity. Heart Lung Circ 23: 764-771, 2014.
7. Ueno K, Anzai T, Jinzaki M, et al. Increased epicardial fat volume quantified by 64-multidetector computed tomography is associated with coronary atherosclerosis and totally occlusive lesions. Circ J 73: 1927-1933, 2009.
8. Fox CS, Gona P, Hoffmann U, et al. Pericardial fat, intrathoracic fat, and measures of left ventricular structure and function: the Framingham Heart Study. Circulation 119: 1586-1591, 2009.
9. Iacobellis G, Assael F, Ribaudo MC, et al. Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. Obes Res 11: 304-310, 2003.
10. Karbek B, Cakal E, Cakir E, et al. Cardiovascular risk factors, carotid artery intima-media thickness, and HSCRP levels in patients with impaired glucose metabolism. Minerva Endocrinol 38: 297-304, 2013.
11. Karbek B, Özbek M, Bozkurt NC, et al. Heart-type fatty acid binding protein (H-FABP): relationship with arterial intima-media thickness and role as diagnostic marker for atherosclerosis in patients with impaired glucose metabolism. Cardiovasc Diabetol 10: 37, 2011.
12. Pezeshkian M, Mahtabipour MR. Epicardial and subcutaneous adipose tissue Fatty acids profiles in diabetic and non-diabetic patients candidate for coronary artery bypass graft. BioImpacts 3: 83-89, 2013.
13. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 2: 358-367, 1989.
14. Centers for disease Control and prevention. National Diabetes Fact sheet: national estimates and general information on diabetes and prediabetes in the United States 2011. US Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA, 2011.
15. Satman I, Omer B, Tutuncu Y, et al; TURDEP-II Study Group. Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur J Epidemiol 28: 169-180, 2013.
16. Gerstein HC, Santaguida P, Raina P, et al. Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies. Diabetes Res Clin Pract 78: 305-312, 2007.
17. The Emerging Risk Factors Collaboration. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 375: 2215-2222, 2010.
18. Seshasai SR, Kaptoge S, Thompson A, et al, For the Emerging Risk Factors Collaboration. Diabetes Mellitus, fasting glucose, and risk of cause-spesific death. N Engl J Med 364: 829-841, 2011.
19. Shaw J, Hodge A, De Courten M, Chitson P, Zimmet P. Isolated post-challenge hyperglycaemia confirmed as a risk factor for mortality. Diabetologia 42: 1050-1054, 1999.
20. Tominaga M, Eguchi H, Manaka H, Igarashi K, Kato T, Sekikawa A. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care 22: 920-924, 1999.
21. Tabak A, Jokela M, Akbaraly T, Brunner E, Kivimaki M, Witte D. Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet 373: 2215-2221, 2009.
22. Vinik A, Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation 115: 387-397, 2007.
23. Iacobellis G, Ribaudo MC, Assael F, et al. Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardivascular risk. J Clin Endocrinol Metab 88: 5163-5168, 2003.
24. Wang TD, Lee WJ, Shih FY, et al. Relations of epicardial adipose tissue measured by multidetector computed tomography to components of the metabolic syndrome are region-specific and independent of anthropometric indexes and intraabdominal visceral fat. J Clin Endocrinol Metab 94: 662-669, 2009.
25. Şengül C, Özveren O. Epicardial adipose tissue: a review of physiology, pathophysiology, and clinical applications. Anadolu Kardiyol Derg 13: 261-265, 2013.
26. Iacobellis G, Willens HJ, Barbaro G, Sharma AM. Threshold values of high-risk echocardiographic epicardial fat thickness. Obesity (Silver Spring) 16: 887-892, 2008.
27. Sironi AM, Pingitore A, Ghione S, et al. Early hypertension is associated with reduced regional cardiac function, insulin resistance, epicardial, and visceral fat. Hypertension 51: 282-288, 2008.
28. Yazıcı D, Özben B, Yavuz D, et al. Epicardial adipose tissue thickness in type 1 diabetic patients. Endocrine 40: 250-255, 2011.
29. Tok D, Ça_li K, Kadife I, et al. Impaired coronary flow reserve is associated with increased echocardiographic epicardial fat thickness in metabolic syndrome patients. Coron Artery Dis 24: 191-195, 2013.
30. Yorgun H, Canpolat U, Hazırolan T, et al. Increased epicardial fat tissue is a marker of metabolic syndrome in adult patients. Int J Cardiol 165: 308-313, 2013.
31. Versteylen MO, Takx RA, Joosen IA, et al. Epicardial adipose tissue volume as a predictor for coronary artery disease in diabetic, impaired fasting glucose, and non-diabetic patients presenting with chest pain. Eur Heart J Cardiovasc Imaging 13: 517-523, 2012.
32. Verhagen SN, Visseren FL. Perivascular adipose tissue: as a cause of atherosclerosis. Atherosclerosis 214: 3-10, 2011.
33. Xu Y, Cheng X, Hong K, Huang C, Wan L. How to interpret epicardial adipose tissue as a cause of coronary artery disease: a metaanalysis. Coron Artery Dis 23: 227-233, 2012.
34. Kim BJ, Kim BS, Kang JH. Echocardiographic epicardial fat thickness is associated with arterial stiffness. Int J Cardiol 167: 2234-2238, 2013.
35. Sengul C, Cevik C, Ozveren O, et al. Echocardiographic epicardial fat thickness is associated with carotid intima-media thickness in patients with metabolic syndrome. Echocardiography 28: 853-858, 2011.
36. Bachar GN, Dicker D, Kornowski R, Atar E. Epicardial adipose tissue as a predictor of coronary artery disease in asymptomatic subjects. Am J Cardiol 110: 534-538, 2012.
37. Gorter PM, de Vos AM, van der Graaf Y, et al. Relation of epicardial and pericoronary fat to coronary atherosclerosis and coronary artery calcium in patients undergoing coronary angiography. Am J Cardiol 102: 380-385, 2008.
38. Akyol B, Boyraz M, Aysoy C. Relationship of epicardial adipose tissue thickness with early indicators of atherosclerosis and cardiac functional changes in obese adolescents with metabolic syndrome. J Clin Res Pediatr Endocrinol 5: 156-163, 2013.
39. Momesso DP, Bussade I, Epifanio MA, et al. Increased epicardial adipose tissue in type 1 diabetes is associated with central obesity and metabolic syndrome. Diabetes Res Clin Pract 91: 47-53, 2011.
40. Fernández Muñoz MJ, Basurto Acevedo L, Córdova Pérez N, et al. Epicardial adipose tissue is associated with visceral fat, metabolic syndrome, and insulin resistance in menopausal women. Rev Esp Cardiol 67: 436-441, 2014.
41. Rabkin SW. The relationship between epicardial fat and indices of obesity and the metabolic syndrome: a systematic review and meta-analysis. Metab Syndr Relat Disord 12: 31-42, 2014.
42. Fu CP, Sheu WH, Lee IT, et al. Effects of weight loss on epicardial adipose tissue thickness and its relationship between serum soluble CD40 ligand levels in obese men. Clin Chim Acta 421: 98-103, 2013.
43. Kokkinos A, Alexiadou K, Liaskos C, et al. Improvement in cardiovascular indices after Roux-en-Y gastric bypass or sleeve gastrectomy for morbid obesity. Obes Surg 23: 31-38, 2013.
44. Iacobellis G, Barbaro G, Gerstain HC. Relationships of epicardial fat thickness and fasting glucose. Int J Cardiol 128: 424-426, 2008.
45. Kim HM, Kim KJ, Lee HJ, et al. Epicardial adipose tissue thickness is an indicator for coronary artery stenosis in asymptomatic type 2 diabetic patients: its assessment by cardiac magnetic resonance. Cardiovasc Diabetol 11: 83, 2012.
46. Aydogdu A, Uckaya G, Tasci I, et al. The relationship of epicardial adipose tissue thickness to clinical and biochemical features in women with polycystic ovary syndrome. Endocr J 59: 509-516, 2012.